Drug intelligence / Profile preview

2,6-diamino-8-propylsulfanylmethyl-3h-quinazoline-4-one

Development stage
Unknown
Modality
Small Molecules
01

Overview

2,6-Diamino-8-propylsulfanylmethyl-3H-quinazoline-4-one is a synthetic small molecule belonging to the quinazolinamine class. It has been studied as an experimental inhibitor of prokaryotic tRNA–guanine transglycosylase (TGT), an enzyme involved in tRNA modification. The compound was designed and evaluated for its ability to bind and inhibit TGT from Zymomonas mobilis and related bacteria. Its mechanism involves competitive inhibition at the active site of TGT by mimicking the natural substrate guanine or its analogues[1][5][10]. There are no approved indications or clinical uses; it is primarily used in biochemical research.

Other names
2,6-diamino-8-(propylsulfanylmethyl)-3h-quinazoline-4-one2,6-diamino-8-propylsulfanylmethylquinazolinone2,6-diamino-8-(propylthio)methylquinazolinone
02

Targets

TGT (Queuine tRNA-ribosyltransferase)

Beyond the preview

Go deeper on 2,6-diamino-8-propylsulfanylmethyl-3h-quinazoline-4-one.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2,6-diamino-8-propylsulfanylmethyl-3h-quinazoline-4-one.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call